Vitabiotics acquired by Bain Capital

Bain Capital agreed to acquire Vitabiotics, a UK vitamins, minerals and supplements (vms) brand, on Jul 24, 2026.

Transaction summary

Target
Vitabiotics
Announced
2026-07-24
Geography
United Kingdom
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-08-09
Latest update
2026-10-18

Parties at the deal date

Acquirer

Bain Capital

Current investor profile →

Bain Capital is one of the world's leading multi-asset alternative investment firms. We have dedicated investment teams and funds spanning Private Equity, Public Equity, Credit, Venture Capital and Real Estate. Founded in 1984, we pioneered a consulting-based approach to private equity investing, partnering closely with management teams to offer the insights that challenge conventional thinking, build great businesses and improve operations. Over time, we have organically expanded this approach across asset classes to build one of the strongest alternative asset platforms in the world. We have offices in the Americas, Europe and Asia Pacific, and our global team aligns our interests with those of our investors and partners for lasting impact.

Snapshot preserved for this transaction; current company profiles may differ.

Value and multiples

100% enterprise value

USD 1.0B

100% enterprise value | USD

Basis: Reported / rumored

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

-

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • Estimated EV of US$1.0375bn averages the US$875m midpoint of Economic Times’ US$850–900m report and Business Standard’s US$1.2bn report (both 24 July 2026). Both cover Vitabiotics, Meyer Organics and African operations. Terms were undisclosed; these are press estimates.

Source summary

Bain Capital to Acquire Vitabiotics, the UK’s No.1 Vitamin Company

Confirmed

Bain Capital press release (July 24, 2026) announces an agreed acquisition of Vitabiotics, including its UK operations and the wider VB Group (Meyer Organics in India and operations in Africa, including VB Egypt). Completion is subject to customary regulatory approvals. Financial terms were not disclosed.

Open source

Economic Times, 24 July 2026

Estimated

the deal values Vitabiotics at $850-900 million

Open source

Business Standard, 24 July 2026

Estimated

the deal is valued at about $1.2 billion

Open source

Continue your research

Explore more comps →